SQ.line KERRISON

SQ.line KERRISON is an FDA 510(k)-cleared medical device (K223596) manufactured by Aesculap, Inc.. This device is classified under the Neurology specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on June 28, 2023. Regulation: 8.